Overview
A mix of small brain-derived peptides that mimic the body’s own nerve growth factors.
Used (mainly in Europe/Asia) for stroke, dementia, and brain-injury recovery in pulsed courses rather than continuous dosing.
What It Does
Cerebrolysin is a porcine-brain-derived peptide preparation with neurotrophic activity resembling BDNF/CNTF/GDNF.
It supports neuronal survival, neuroplasticity, and repair.
Clinically given as pulsed courses (e.g. daily for 10–20 days, then a rest).
Note: pharmaceutical Cerebrolysin is a concentrated solution dosed in mL (grams/day); research-vial formats are far smaller microdoses.
Reconstitution
| Vial Size | BAC Water / Solvent | Concentration |
|---|---|---|
| 60 mg | + 2 mL | 30 mg/mL |
Reconstitution Calculator
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Enter a target amount you already have and select the syringe capacity.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
Protocol
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Course (10– | Daily | ~10 mg (research- | SubQ or IM. Max 5 mL per IM site for clinical solution; research-vial volumes |
| Rest | 2–8 weeks | – | Pulsed courses let neurotrophic effects consolidate between rounds. |
10–20 day courses separated by 2–8 week rests; several courses per year is the clinical pattern.
daytime (can be mildly activating). Dose reality: pharmaceutical Cerebrolysin is dosed at 5–30 mL of a 215 mg/mL solution (1–6 g/day); the mg-format research vials here deliver far less, manage expectations accordingly.
Unisex neurotrophic mixture, dosed by protocol, not sex; used in both sexes in stroke/dementia trials. Avoid in pregnancy.
Handling & Stacking
- Freeze-dried: -4°F.
- Reconstituted: 36–46°F, a manufactured solution rather than a reconstituted powder, so follow the sealed-ampoule label; grey-market lyophilized vials carry no label and should be treated as ~2–4 weeks (structure-based estimate).
- Protect from light.
- Gradual cognitive/recovery support over a course; effects build across pulsed cycles.
- Best evidence is in stroke/dementia/TBI populations.
- Supply math 60mg → ~4 vials (20-day course @ ~10 mg/day, research-vial basis)
